Business
Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine
Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine.
About this update from Cnbx Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nNeuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nNeuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine\nPR Newswire\nTEL AVIV, Israel and BETHESDA, Md., Sept. 13, 2021\n\n\n\nTEL AVIV, Israel and BETHESDA, Md., Sept. 13, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine and a pioneer in the development of psychedelic inspired medicine, announced today that Dr. Ilya Reznik (MD), a renowned Neuropsychiatrist, has joined the company as Head of Psychedelic Inspired Medicine. \n\n \n \n \n \n \n \n\n \nThe nomination of Dr. Reznik is part of the company's strategy to develop new psychedelic inspired medicines and therapies to address several mental health related conditions. The announcement follows the company's recent launching of a Psilocybin and Psilocin Research Program taking place under license by Israeli Ministry of Health.\nEyal Barad, Cannabics Pharmaceuticals' CEO, commented: \"It is with great pleasure that I welcome Dr. Reznik to our team. Dr. Reznik is a world-renowned Neuropsychiatrists with ample experience and accomplishments in his field of specialty, including having conducted research using psychedelic compounds. I look forward to working with him, and I am certain that he will help drive the company's psychedelic inspired development program forward successfully.\"\nDr. Ilya Reznik commented: \"It is a great honor to have been invited to join the team of Cannabics Pharmaceuticals, a well-known leader in the field of cannabinoid-based medicine development. The company's established facilities, experience and knowhow, are an excellent foundation upon which we will now build a new development program for Psychedelic Inspired Medicine, and I look forward to working with the Cannabics team in making this a successful venture that could potentially help large groups of patients suffer...